Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset
Hill, Michael P., Bezard, Erwan, McGuire, Steven G., Crossman, Alan R., Brotchie, Jonathan M., Michel, Ann, Grimée, Renee, Klitgaard, Henrik
Published in Movement disorders (01.11.2003)
Published in Movement disorders (01.11.2003)
Get full text
Journal Article
Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
Savola, Juha-Matti, Hill, Michael, Engstrom, Mia, Merivuori, Hannele, Wurster, Siegfried, McGuire, Steven G., Fox, Susan H., Crossman, Alan R., Brotchie, Jonathan M.
Published in Movement disorders (01.08.2003)
Published in Movement disorders (01.08.2003)
Get full text
Journal Article
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
Hill, Michael P., Ravenscroft, Paula, McGuire, Steven G., Brotchie, Jonathan M., Crossman, Alan R., Rochat, Catherine, Millan, Mark J.
Published in Movement disorders (01.12.2006)
Published in Movement disorders (01.12.2006)
Get full text
Journal Article
Antiparkinsonian effects of the novel D 3 /D 2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D 2 , not D 3 , dopamine receptors
Hill, Michael P., Ravenscroft, Paula, McGuire, Steven G., Brotchie, Jonathan M., Crossman, Alan R., Rochat, Catherine, Millan, Mark J.
Published in Movement disorders (01.12.2006)
Published in Movement disorders (01.12.2006)
Get full text
Journal Article
Fipamezole (JP-1730) is a potent a2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
Savola, Juha-Matti, Hill, Michael, Engstrom, Mia, Merivuori, Hannele, Wurster, Siegfried, McGuire, Steven G, Foxcp, Susan H, Crossman, Alan R, Brotchie, Jonathan M
Published in Movement disorders (01.08.2003)
Published in Movement disorders (01.08.2003)
Get full text
Journal Article
Fipamezole (JP‐1730) is a potent α 2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease
Savola, Juha‐Matti, Hill, Michael, Engstrom, Mia, Merivuori, Hannele, Wurster, Siegfried, McGuire, Steven G., Fox, Susan H., Crossman, Alan R., Brotchie, Jonathan M.
Published in Movement disorders (01.08.2003)
Published in Movement disorders (01.08.2003)
Get full text
Journal Article
Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
Savola, Juha-Matti, Hill, Michael, Engstrom, Mia, Merivuori, Hannele, Wurster, Siegfried, McGuire, Steven G, Fox, Susan H, Crossman, Alan R, Brotchie, Jonathan M
Published in Movement disorders (01.08.2003)
Get full text
Published in Movement disorders (01.08.2003)
Journal Article